A triple-action GH blend combining GHRH stimulation, GHRP pulsatility, and local muscle growth factor for comprehensive GH optimization.
Molecular Weight
Half-Life
Varies
Typical Dose
0.8 mg to 2.4 mg
Cycle Length
8–16 weeks
Description
This pre-formulated blend combines three complementary peptides: Tesamorelin (GHRH analog for sustained GH release), Ipamorelin (selective GHRP for pulsatile GH), and MGF (Mechano Growth Factor for local muscle repair and growth). Together they provide synergistic GH optimization with added anabolic support.
Key Characteristics
Molecular Formula
Molecular Weight
Half-Life
Administration RoutesSubcutaneous injection
Typical Dose0.8 mg to 2.4 mg
FrequencyDaily or as directed
Investigated Benefits
Synergistic GH release
Improved body composition
Local muscle repair (MGF)
Enhanced recovery
Reduced visceral fat (tesamorelin)
* Benefits based on preclinical/animal research unless otherwise noted.
Peptide Protocol Education Portal
Members-Only Access
Access advanced peptide education, protocol insights, and research-based information curated for informed users. Create a free account or log in to continue.
Please acknowledge the disclaimer above to continue.